Sphenopalatine Ganglion Block in Septorhinoplasty

The Effect of Sphenopalatine Ganglion Block on Intraoperative Remifentanil Consumption and Postoperative Pain in Septorhinoplasty Surgery

Septorhinoplasty is a widely performed surgery that aims to correct both functional and aesthetic problems of the nose. Despite its expected clinical benefits, septorhinoplasty surgery causes postoperative pain, which affects the patient's functional recovery and satisfaction. Opioids, Non-steroidal anti-inflammatory drugs (NSAII), acetaminophen and local anesthetics are used in peroperative pain management in septorhinoplasty. Sphenopalatine ganglion block (SPGB), which has been recently described and has different application areas, is a regional analgesia technique that has been investigated for this purpose. Although there are studies on postoperative pain in septorhinoplasty surgeries, there are not enough studies on its effects on intraoperative pain.

This study may have positive effects on appropriate pain management, patient comfort and surgical outcomes as multimodal analgesia management in septorhinoplasty surgeries, and may make significant contributions to evidence-based practices.

Inclusion Criteria:

• Undergoing septorhinoplasty surgery
• Ages between 18-65
• ASA (American Society of Anesthesiologists) score I-II

Exclusion Criteria:

• Unavailable postoperative pain scores and analgesic use in the hospital registry system
• Local anesthetic drug allergy and toxicity
• Advanced organ failure
• Mental retardation

Patients who are pregnant